Eulogio Conde
About
Eulogio Conde is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics.
According to data from OpenAlex, Eulogio Conde has authored 43 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 25 papers in Oncology and 13 papers in Genetics. Recurrent topics in Eulogio Conde's work include Lymphoma Diagnosis and Treatment (28 papers), Viral-associated cancers and disorders (14 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Eulogio Conde is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Viral-associated cancers and disorders (14 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Eulogio Conde collaborates with scholars based in Spain, Germany and France. Eulogio Conde's co-authors include Reyes Arranz, Marı́a Dolores Caballero, José Rodríguez, Antonio Gutiérrez, Carmen Albó, Ángel León, Anna Sureda, Josep‐María Ribera, Maurizio Bendandi and Julián Marín and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.
In The Last Decade
Eulogio Conde
42 papers receiving 848 citations
Peers
Eulogio Conde
Alain Devidas France
Joan H. Admirand United States
B. Glaß Germany
Liuyan Jiang United States
Geraldine Pinkus United States
José R. Valbuena United States
Francesco Zallio Italy
K.F. Wong China
Eddie Hu United States
J Sklar United States
Citations per year, relative to Eulogio Conde Eulogio Conde (= 1×)
peers
Alain Devidas
Countries citing papers authored by Eulogio Conde
Since
Specialization
Citations
This map shows the geographic impact of Eulogio Conde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eulogio Conde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eulogio Conde more than expected).
Fields of papers citing papers by Eulogio Conde
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eulogio Conde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eulogio Conde. The network helps show where Eulogio Conde may publish in the future.
Co-authorship network of co-authors of Eulogio Conde
This figure shows the co-authorship network connecting the top 25 collaborators of Eulogio Conde. A scholar is included among the top collaborators of Eulogio Conde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eulogio Conde. Eulogio Conde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Steegmann, Juan Luis, Dolors Colomer, María Teresa Gómez‐Casares, et al.. (2017). An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase. Journal of Cancer Research and Clinical Oncology. 143(10). 2059–2066.
2.
Cabrero, Mónica, Alejandro Martı́n, Javier Briones, et al.. (2016). Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial. Biology of Blood and Marrow Transplantation. 23(1). 53–59.
3.
Yáñez, Lucrecia, et al.. (2016). Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation. Blood. 128(22). 5737–5737.
4.
Villambrosía, Sonia González de, et al.. (2016). Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options. Expert Review of Anticancer Therapy. 16(4). 411–421.
5.
Fariñas-Álvarez, Concepción, J. Gonzalo Ocejo‐Vinyals, Pablo Sánchez‐Velasco, et al.. (2014). Mannose-binding lectin gene variants and infections in patients receiving autologous stem cell transplantation. BMC Immunology. 15(1). 17–17.
6.
Sancho, Juan‐Manuel, David Serrano, Pascual Balsalobre, et al.. (2011). Comparación de dos estrategias iniciales de movilización de progenitores hematopoyéticos de sangre periférica para trasplante autogénico en pacientes con linfomas e infección por el virus de la inmunodeficiencia humana. Medicina Clínica. 139(5). 192–196.
7.
Bermúdez, Arancha, A. Insunza, J Baró, et al.. (2011). FLAGIDA‐lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts‐2 and is feasible as outpatient treatment. American Journal of Hematology. 87(1). 42–44.
8.
Mounier, Nicolas, Carmen Canals, Christian Gisselbrecht, et al.. (2011). High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry. Biology of Blood and Marrow Transplantation. 18(5). 788–793.
9.
Sánchez‐Espiridión, Beatriz, Abel Sánchez‐Aguilera, Carlos Montalbán, et al.. (2009). A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples. Clinical Cancer Research. 15(4). 1367–1375.
10.
Sáez, Ana I., Mónica García‐Cosío, Antonio José Sáez-Castillo, et al.. (2009). Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 50(4). 571–581.
11.
Robledo, Cristina, Juan Luis Garcı́a, Dolores Caballero, et al.. (2009). Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B‐cell lymphomas. Cancer. 115(16). 3728–3737.
12.
Arellano, Félix, et al.. (2009). Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. Journal of Allergy and Clinical Immunology. 123(5). 1111–1116.e13.
13.
Sancho, Juan‐Manuel, Mireia Morgades, Reyes Arranz, et al.. (2008). Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study. Medicina Clínica. 131(11). 401–405.
14.
Rodríguez, José, Eulogio Conde, Antonio Gutiérrez, et al.. (2008). Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GEL‐TAMO experience. Hematological Oncology. 26(3). 171–178.
15.
Rodríguez, José, Eulogio Conde, Antonio Gutiérrez, et al.. (2007). Prolonged survival of patients with angioimmunoblastic T‐cell lymphoma after high‐dose chemotherapy and autologous stem cell transplantation. The GELTAMO experience. European Journal Of Haematology. 78(4). 290–296.
16.
Arranz, Reyes, Eulogio Conde, Carlos Grande, et al.. (2007). Dose‐escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem‐cell transplantation in poor‐risk aggressive B‐cell lymphoma: a prospective study from the GEL–TAMO Study Group. European Journal Of Haematology. 80(3). 227–235.
17.
Rodríguez, José, Eulogio Conde, Antonio Gutiérrez, et al.. (2007). Frontline autologous stem cell transplantation in high‐risk peripheral T‐cell lymphoma: a prospective study from The Gel‐Tamo Study Group. European Journal Of Haematology. 79(1). 32–38.
18.
Rodríguez, José A., Marı́a Dolores Caballero, Antonio Gutiérrez, et al.. (2005). Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.. Blood. 106(11). 2082–2082.
19.
Serrano, David, Rafael Carrión, Pascual Balsalobre, et al.. (2005). HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Experimental Hematology. 33(4). 487–494.
20.
Lahuerta, Juan José, Carlos Grande, Joaquín Martínez‐López, et al.. (2003). Tandem transplants with different high‐dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial. British Journal of Haematology. 120(2). 296–303.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alain Devidas Breakdown of academic impact, for papers by Joan H. Admirand Breakdown of academic impact, for papers by B. Glaß Breakdown of academic impact, for papers by Liuyan Jiang Breakdown of academic impact, for papers by Geraldine Pinkus Breakdown of academic impact, for papers by José R. Valbuena Breakdown of academic impact, for papers by Francesco Zallio Breakdown of academic impact, for papers by K.F. Wong Breakdown of academic impact, for papers by Eddie Hu Breakdown of academic impact, for papers by J Sklar